Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have been given a consensus rating of “Hold” by the six research firms that are presently covering the company, Ratings reports. Five ...

He also highlighted that the DOJ's review of UNH's purchase of LHC Group ... RBC's Hendrix raised his price target on ...

However, UnitedHealth Group and Amedisys allege the lawsuit essentially ignores the companies' proposed divestiture package. The company didn’t identify which locations would be sold ...

Amedisys stock opened at $92.78 on Wednesday. The stock has a fifty day moving average of $89.98 and a 200 day moving average of $93.68. Amedisys has a one year low of $82.15 and a one year high ...

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. BATON ROUGE, La., Feb ...

Shares of UnitedHealth (NYSE:UNH) fell 4.6% Monday as concerns mounted over its pending merger with Amedisys (NASDAQ:AMED) following the announcement that the FTC will maintain Biden-era merger rules.

of Justice filed a lawsuit to block UnitedHealth's (UNH) planned $3.3 billion acquisition of Amedisys (AMED ... regulatory ...

UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...